Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.
FDA orders “limited distribution” for lung cancer drug Iressa.
House approves $210 million for Dept. of Defense cancer research programs.
House Committee on Appropriations approves $28.5 billion for NIH.
House panel investigating NIH handling of tissue specimens.
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Chernobyl: a 35 year follow up on long-term health effects
- Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts - Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions